Join the Seizure Prophylaxis group to help and get support from people like you.
Seizure Prophylaxis News (Page 3)
Two Common Antiseizure Medications Do Not Harm Child Neurodevelopment
TUESDAY, Dec. 3, 2024 -- Fetal exposure to two common antiseizure medications (ASMs) does not seem to negatively impact children's neurological development at age 6 years, according to a study pu...
Newer Epilepsy Meds Safe During Pregnancy, Won't Affect Kids' Neurodevelopment
MONDAY, Dec. 2, 2024 – For decades, it's been known that certain older medications women use to control epilepsy seizures can pose risks to a fetus. However, data now suggests that no such risk ...
In Utero Exposure to Certain Antiepileptics Tied to Neurodevelopmental Diagnoses
MONDAY, Nov. 25, 2024 – Exposure to certain antiseizure medications (ASMs) in utero is associated with an increased likelihood of neurodevelopmental diagnoses, according to a study published online...
Risk for Suicide Two Times Higher for Those With Epilepsy Versus General Population
WEDNESDAY, Nov. 20, 2024 – The prevalence of suicide is higher among those with epilepsy compared with the general population, according to a study published in the December issue of Epilepsy &...
Ordinal Score Predicts Freedom From Epilepsy One Year After Surgery
TUESDAY, Nov. 5, 2024 – An ordinal score incorporating eight independent binary clinical variables shows good performance for predicting seizure freedom one year after surgery for mesial temporal...
Single-Substance Exposures Causing Seizures Increased in U.S. Children, 2009 to 2023
FRIDAY, Oct. 18, 2024 – Seizures associated with pediatric single-substance exposures are steadily increasing, according to a study presented at the European Emergency Medicine Congress, held from...
Retinal Neuroaxonal Loss Detectable With Epilepsy
THURSDAY, Oct. 17, 2024 – In people with epilepsy, progression of retinal neuroaxonal loss is detectable at short-term follow-up, according to a study published online Oct. 9 in Epilepsia. Livia ...
Gut Flora Differs in Patients With Epilepsy and Cognitive Dysfunction
WEDNESDAY, Oct. 16, 2024 – There is an imbalance in the gut flora of patients with epilepsy compared with healthy controls, according to a study published online Sept. 28 in the Journal of Health, ...
More Kids Having Seizures After Swallowing Rx Painkillers, Diphenhydramine, Synthetic Pot
WEDNESDAY, Oct. 16, 2024 – The number of U.S. children who suffer seizures after swallowing prescription medications or illicit drugs has doubled in recent years, a new study finds. Drug poisonings...
Maternal Influenza Infection in Pregnancy Tied to Seizures in Offspring
TUESDAY, Sept. 24, 2024 – Maternal influenza infection during pregnancy is associated with an increased risk for seizures and febrile convulsions in offspring, according to a study published online...
Paternal Antiseizure Rx Use at Conception Does Not Pose Risk to Offspring
MONDAY, Sept. 23, 2024 – Limited data indicate that paternal exposure to antiseizure medications (ASMs) at conception is unlikely to pose any major risk for adverse outcomes for offspring, according...
FDA Approves Valtoco (diazepam nasal spray) as a Seizure Rescue Treatment
SAN DIEGO, CA – January 13, 2020 – Neurelis, Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved Valtoco (diazepam nasal spray) as an acute treatment of intermittent, s...
FDA Approves Diacomit (stiripentol) for Seizures Associated with Dravet Syndrome
On August 20, 2018, the U.S. Food and Drug Administration (FDA) approved Diacomit (stiripentol) for seizures associated with Dravet syndrome in patients 2 years of age and older taking clobazam. ...
FDA Approves Carnexiv (carbamazepine) injection as Intravenous Short-Term Replacement Therapy for Certain Seizure Types
DEERFIELD, Ill.--(BUSINESS WIRE) October 07, 2016 --Lundbeck announced today that the U.S. Food and Drug Administration (FDA) has approved Carnexiv (carbamazepine) injection as a short-term...
FDA Approves Briviact (brivaracetam) to Treat Partial Onset Seizures
February 19, 2016 – The U.S. Food and Drug Administration yesterday approved Briviact (brivaracetam) as an add-on treatment to other medications to treat partial onset seizures in patients age 16...
Further information
Related condition support groups
Related drug support groups
Klonopin, clonazepam, Lamictal, Valium, diazepam, Topamax, lamotrigine, topiramate